[Substitution therapy of hemorrhagic diseases].
D000347:Afibrinogenemia / Q000188:drug therapy; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D001803:Blood Transfusion; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D006395:Hemarthrosis / Q000188:drug therapy; D006467:Hemophilia A / Q000188:drug therapy; D002836:Hemophilia B / Q000188:drug therapy; D006801:Humans; D010949:Plasma; D010952:Plasma Substitutes / Q000627:therapeutic use; D013997:Time Factors
D001779:Blood Coagulation Factors; D010952:Plasma Substitutes; D005169:Factor VIII; D005164:Factor IX; D005340:Fibrinogen
Substitutionsbehandlung von Blutungskrankheiten